- ¥2bn
- ¥1bn
- ¥1bn
- 52
- 24
- 24
- 21
Annual income statement for SecuAvail, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,190 | 1,200 | 957 | 1,029 | 1,099 |
Cost of Revenue | |||||
Gross Profit | 457 | 497 | 373 | 414 | 443 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,121 | 1,153 | 1,051 | 1,068 | 1,171 |
Operating Profit | 69.5 | 46.9 | -94.3 | -39.2 | -71.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 70 | 61.8 | -85.6 | -35.2 | 344 |
Provision for Income Taxes | |||||
Net Income After Taxes | 56.7 | 46.2 | -112 | -44 | 229 |
Net Income Before Extraordinary Items | |||||
Net Income | 56.7 | 46.2 | -112 | -44 | 229 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 56.7 | 46.2 | -112 | -44 | 229 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.2 | 4.1 | -14.4 | -5.35 | 33.2 |
Dividends per Share | |||||
Special Dividends per Share |